Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Dasatinib enhances the expansion of CD56+CD3- NK cells from cord blood.

× No keyword cloud information.

5 in total

1. Phase I study of cellular therapy using ex vivo expanded natural killer cells from autologous peripheral blood mononuclear cells combined with rituximab-containing chemotherapy for relapsed CD20-positive malignant lymphoma patients.

Authors: Junji Tanaka; Norina Tanaka; Yan-Hua Wang; Kenjiro Mitsuhashi; Michiko Ryuzaki; Yuki Iizuka; Aya Watanabe; Midori Ishiyama; Akihito Shinohara; Hiroshi Kazama; Shotaro Hagiwara; Kentaro Yoshinaga; Yumi Kougen; Hirohito Kobayashi; Hitoshi Kanno; Masayuki Shiseki
Journal: Haematologica Date: 2019-08-08 Impact factor: 9.941

Review 2. Large granular lymphocytosis during dasatinib therapy.

Authors: Zhi-Yuan Qiu; Wei Xu; Jian-Yong Li
Journal: Cancer Biol Ther Date: 2013-12-18 Impact factor: 4.742

3. NKG2D gene polymorphisms are associated with disease control of chronic myeloid leukemia by dasatinib.

Authors: Ryujiro Hara; Makoto Onizuka; Erika Matsusita; Eri Kikkawa; Yoshihiko Nakamura; Hiromichi Matsushita; Daisuke Ohgiya; Hiromichi Murayama; Shinichiro Machida; Ken Ohmachi; Yukari Shirasugi; Yoshiaki Ogawa; Hiroshi Kawada; Kiyoshi Ando
Journal: Int J Hematol Date: 2017-08-09 Impact factor: 2.490

Review 4. Cellular engineering and therapy in combination with cord blood allografting in pediatric recipients.

Authors: M S Cairo; N Tarek; D A Lee; C Delaney
Journal: Bone Marrow Transplant Date: 2015-09-14 Impact factor: 5.483

Review 5. Improving engraftment and immune reconstitution in umbilical cord blood transplantation.

Authors: Robert Danby; Vanderson Rocha
Journal: Front Immunol Date: 2014-02-24 Impact factor: 7.561

5 in total